Exciting News! Integral Secures $6.9 Million in Seed Funding

John Kuhn: Co-Founder and CTO

At Integral, we are thrilled to share the exciting news of the successful completion of our $6.9 million seed round! This achievement marks a significant milestone in our ongoing mission to transform the landscape of healthcare data accessibility and compliance. The infusion of funds we've received will be instrumental in advancing Integral's core objectives, which revolve around safeguarding sensitive health data and delivering cutting-edge, automated expert certification software. We aim to empower health and life sciences companies with expedited access to compliant, invaluable, and de-identified data, reducing the wait time from months to near real-time.

This journey was made possible through the support of our lead investors, Haystack, The General Partnership, and Virtue Ventures, along with the invaluable contributions from Also Capital, Array Ventures, Caffeinated Capital, GreatPoint Ventures, LiveRamp Ventures, and Venrex.

We are also fortunate to have garnered backing from industry luminaries who are experts in healthcare and technology. Our esteemed advisors include Jason Brenner, Regional Vice President for Healthcare and Life Sciences at LiveRamp, and Dr. Bradley Malin, Vice Chair for Research and Professor of Biomedical Informatics at Vanderbilt University. Our circle of angel investors is equally impressive, featuring Andrew Arruda, co-founder and CEO at Flexpa; Abhishek Chandra, co-founder and CEO at Recora Health; Joel Jewitt, co-founder and Vice President at LiveRamp; Michel Tricot, co-founder and CEO at Airbyte; Sam Whitaker, founder and CEO at Mural Health; and other notable individuals who share our vision and enthusiasm.

Shubh and I created Integral with a shared vision: Allow healthcare companies to work with healthcare data at unprecedented speed by de-identifying and certifying data through automation. Before Integral, companies were forced to rely on labor-intensive expert certifications performed by consultants, a time-consuming and manual procedure that often spanned several months and left usable data untapped. Integral changes the game by providing higher quality data and expert Certification-as-a-Service software, enabling customers to work with better data in nearly real-time.

"Integral addresses a critical need for data privacy automation within life sciences and healthcare organizations, and we see this as a core workflow for these large customers over the coming years," said Aashay Sanghvi, Partner, Haystack. "By streamlining privacy compliance, Integral enables companies to operate with data safely and expediently, which helps them get new treatments to market faster and serve patients better."

Integral streamlines dataset creation by automating the de-identification and compliance certification process. Personal and highly revealing healthcare data such as medical records, health histories, and genetic information, when combined with non-healthcare data such as social media activity, purchasing history, and location data, give researchers a deep, holistic understanding of a person's health and lifestyle. While this combined data set enhances healthcare research and improves health outcomes, it can pose a significant threat to people's privacy by potentially exposing sensitive information about individuals.

"Combining healthcare and non-healthcare data can transform healthcare research and innovation. John and I asked why healthcare companies couldn't buy and analyze data as quickly as retailers like Target or Walmart, and we've made that possible with Integral. We've proven and will continue to prove that speed, accuracy, and privacy can be treated equally, even when working with highly regulated data," said Sinha. "We created Integral to achieve this goal, ensuring personal information is protected and people's privacy rights are respected. By prioritizing privacy and building trust with the public, researchers can unlock more value from data, which leads to better clinical trials, medications, products, technologies, and more."

We've already brought on highly experienced healthcare expert Timothy Nobles, who shares 18+ years of experience in large-scale, privacy-preserving data solutions in Healthcare and Fintech. Timothy will bolster commercial efforts as we broaden and scale go-to-business capabilities in its key markets and further develop proprietary platform capabilities with this new round of funding.

According to Amruta Moktali, Chief Product Officer at Skyflow, an Integral partner, "We are seeing incredible momentum for adoption of LLM in regulated industries like healthcare. Skyflow's data privacy vault offers a complete data privacy layer for LLMs. Our partnership with Integral allows our customers to get expert certification in days rather than weeks and months."

Our team will be attending Pharma East 2023. If you're interested in setting up meetings with us, please email shubh.sinha@useintegral.com.

View the press release in its original form here.

Copyright Promeed Inc. 2022